Manchester Financial Inc Astrazeneca PLC Transaction History

Manchester Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 20, 2020	SELL	$37.79 - $51.33 $32,008 - $43,476	-847 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$42.46 - $50.46 $35,963 - $42,739	847 New	847 $42,000
Q3 2019 Oct 09, 2019	SELL	$40.12 - $45.47 $24,072 - $27,282	-600 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$37.28 - $41.68 $22,368 - $25,008	600 New	600 $25,000

1,336

477M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.